A B S T R A C T Isolated rat lungs were ventilated with air and perfused with a blood-free Krebs-Ringer bicarbonate solution under conditions of net CO2 elimination in the lung. Some of the effluent perfusate was drawn through a stop-flow pH electrode apparatus, arriving at the electrode within 4 s after passing through the pulmonary capillaries. pH and temperature of the fluid in the electrode chamber were continuously monitored both before and after withdrawal was suddenly stopped. Little or no change was observed in the pH of the perfusate after flow was stopped, despite the fact that CO2 was eliminated in the lung, suggesting that the conversion of H2CO3 to CO2 in the blood-free perfusion fluid was markedly accelerated and the rise in pH was complete by the time the perfusate reached the electrode. Because the effluent perfusate was shown to be free of carbonic anhydrase activity, the catalysis must have occurred during transit through the isolated lung. When acetazolamide was added to the perfusate, a rise in the pH of the perfusate after stopping flow was consistently seen. These results suggest that the carbonic anhydrase of isolated lungs accelerates the conversion of H2CO3 to CO2 and enhances CO2 elimination as perfusate passes through the pulmonary capillaries, and that the enzyme may be present on the capillary endothelial surface.
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INTRODUCTION
In vitro studies of CO2 and H+ equilibration in erythrocyte suspensions led to predictions (1) (2) (3) that the plasma pH in arterial blood would continue to change after the blood leaves the pulmonary capillaries in vivo. Attempts to verify this prediction in animal studies have been difficult (4 the slow pH changes that have been found in normal animals in vivo are smaller in magnitude than expected (5, 6) . These findings caused us to consider the possibility that carbonic anhydrase, long thought to be present in lung tissue (7), can directly catalyze the conversion of plasma H2CO3 to CO2 as blood passes through the lung capillaries, thus both enhancing pulmonary CO2 exchange and decreasing the magnitude of the slow downstream plasma pH changes.
To study this possibility, isolated ventilated rat lungs were perfused with a blood-free Krebs-Ringer bicarbonate (KRB)1 solution under conditions of net CO2 elimination in the lung. The pH of the effluent perfusate, monitored in a stop-flow electrode apparatus, showed little or no change with time after leaving the lung. When acetazolamide was added to the perfusing fluid, a rise in the pH of the effluent perfusate was observed. These results indicate that (a) carbonic anhydrase ofisolated rat lungs in these experiments accelerated the conversion of perfusate H2CO3 to CO2, (b) lung tissue carbonic anhydrase may be present on the capillary endothelium, and (c) if the enzyme activity is accessible to plasma HCO-in vivo, slow postcapillary pH changes may be smaller than previously predicted.
METHODS
Male Sprague-Dawley rats (210-410 g) were anesthetized with 50 mg/kg i.p. pentobarbital sodium. A tracheostomy was performed and the lungs were mechanically ventilated (Harvard model 680 ventilator, Harvard Apparatus Co., Millis, Mass.) with room air. The abdomen was opened and blood cleared from the pulmonary circulation by infusing KRB perfusate (37°C) into the portal vein after cutting the abdominal aorta. The chest was then opened and the perfusate infused at about 20 ml/min (Cole-Parmer 7014 pump, Cole-Parmer Instrument Co., Chicago, Ill.) through a pulmonary artery cannula. The lungs were removed from the thoracic cavity, a cannula was placed in the left atrium, and the lungs were hung in a water-jacketed chamber. Effluent IAbbreviation used in this paper: KRB, Krebs-Ringer bicarbonate.
perfusate was not recirculated. Pressure transducers (Statham P23, Statham Instruments, Inc., Oxnard, Calif.) were used to monitor tracheal airway and pulmonary artery pressures. A schematic diagram of the perfusion system is shown in Fig. 1 .
The left atrial cannula was connected through the wall of the water jacket to a T-tube connector, one arm of which drained freely. The other arm was connected to the stopflow pH electrode apparatus. This apparatus has been described in detail previously (4) and is shown schematically in Fig. 1 . Fluid was withdrawn through the apparatus at 15 ml/min, making certain that flow always continued out through the open arm of the T tube throughout the withdrawal. After about 10-15 ml of fluid had been withdrawn, the flow through the electrode was suddenly terminated. Temperature and pH of the fluid in the electrode chamber were monitored both before and after flow was stopped, recorded on a storage oscilloscope screen (Tektronix 5103N, Tektronix, Inc., Beaverton, Oreg.), and photographed. pH changes as small as ±0.002 were measurable. The transit time of perfusate from pulmonary capillaries to the electrode was estimated at about 4 s by a method described previously (4) .
The KRB perfusate consisted of 118.5 mM NaCl, 1.3 mM CaC12, 4.7 mM KC1, 1.2 mM MgSO4, 1.2 mM KH2PO4, and 23.3 mM NaHCO3. The same fluid was in both reservoirs A and B ( Fig. 1 ) except that B also contained 0.25 mg/ml acetazolamide. Both perfusates (A and B) were preequilibrated with gas mixtures to pH -7.4, Pco2 39 mm Hg, and Po2 -48 mm Hg.
After hanging the lung, experimental runs were performed with perfusate A. Within several minutes of performing a run, samples of inflowing and effluent perfusate were collected anaerobically, and their pH, Pco2, and Po2 measured independently on a blood-gas machine (Radiometer BMS3 Mk 2, Radiometer Co., Copenhagen, Denmark). The lung was then switched to perfusate B and the procedure repeated within 1-20 min. Subsequently, in several lungs, the perfusate was switched back once again to A and the procedure again repeated after 5-10 min.
Hemoglobin concentration in the effluent perfusate was measured spectrophotometrically at 412 nm. Carbonic anhydrase activity was determined by mixing perfusate (inflowing or effluent) with 10 mM HCI in a rapid-reaction apparatus (8) and observing the kinetics of dehydration of H2CO3.
RESULTS
Sequential records from experimental runs in a typical lung (rat 4) with perfusate A (acetazolamide free), B (containing 0.25 mg/ml acetazolamide), and A again are shown in Fig. 2a, 2b , and 2c. Corresponding pH, Pco2, and Po2 of the inflowing and effluent perfusates are given in Table I . The tracings at the left side of each record represent pH (upper trace) and temperature (lower trace) during fluid withdrawal through the electrode. Small respiratory oscillations in pH can be seen (4). After flow stopped, the temperature of the fluid in the electrode chamber changed <0.1°C in all runs. pH in effluent perfusate A also did not change ( Fig. 2a  and 2c ), whereas that in perfusate B (Fig. 2b) rose 0.05 with t112 -3.5 s.
A summary of results is given in Table I . In each lung, there was little or no change observed in the pH of the effluent perfusate after stopping flow when perfusate A was used. With perfusate B, however, there was always a marked rise in fluid pH. The difference was significant (P < 0.000001). Each entry in 4. Perfusate was drawn through the electrode chamber at a constant rate of 15.3 ml/min until withdrawal was suddenly stopped (as indicated). The record (a) was obtained first with KRB perfusate from reservoir A. After switching to (KRB plus acetazolamide) perfusate from reservoir B the record (b) was obtained. The perfusate was then changed back to that from reservoir A and record (c) was obtained.
When perfusate passes through the pulmonary capillaries in our experiments, CO2 leaves the fluid and is eliminated with expired gas (Fig. 3 ). This causes a disequilibrium which drives H2CO3 toward CO2. For the levels of pH and Pco2 in our experiments, this process, if uncatalyzed, occurs slowly (4), so the pH change associated with it should be observable in our electrode apparatus. We saw little or no change in effluent fluid pH with perfusate A (Fig. 2a) , meaning that the reaction was accelerated before the fluid entered the electrode. Because the effluent perfusate contained no carbonic anhydrase activity, this catalysis must have occurred as the perfusate passed through the lung. We conclude that it is the lung's own carbonic anhydrase which is accessible to the perfusate and catalyzes the conversion of H2CO3 to CO2, although the location of the enzyme in the lung is not exactly known. 3 Reactions involving CO2 in the pulmonary capillary during CO2 elimination in the lung. The figure is drawn as though the site of catalysis is on the capillary endothelial surface although the actual site ofcatalysis is unknown.
With perfusate B, we observed an increasing pH with time in the stop-flow electrode (Fig. 2b) , indicating that this sulfonamide is capable of getting to and inhibiting the lung enzyme. Furthermore, total pH change across the lung as measured in the blood-gas machine was diminished with perfusate B relative to that with A (Table I ). These findings indicate that lung carbonic anhydrase accelerates the CO2 reactions in A while the perfusate is still within the pulmonary capillaries. Acetazolamide can be washed away from its site of interaction with the lung carbonic anhydrase, as shown by the reversal of inhibition (Fig. 2c) .
The sum of the pH change observed for perfusate B in the stop-flow electrode and the pH change that should have occurred during the transit time between lung and electrode will equal the total pH change measured in the blood-gas machine for perfusate B if acetazolamide totally inhibits the lung carbonic anhydrase. To investigate the extent of inhibition, we used a mathematical model to compute the timecourse of pH change in our perfusate B as a result of a sudden fall in Pco2 as might occur in the lungs. The model was similar to that developed by Gray (9) , except that total CO2 content after the initial fall in Pco2 was kept constant in our calculations. The pH change computed for the lung-to-electrode transit time plus that observed in the stop-flow electrode for perfusate B was approximately the same as that measured in the blood-gas machine. We conclude that the acetazolamide in perfusate B (0.25 mg/ml) completely inhibited the lung carbonic anhydrase within 1 min after perfusion with B was begun. Based on the total pH change in perfusate A measured in the blood-gas machine, and the mean stop-flow pH change in A (Table I) (10) . Because the actual site of catalysis is unknown, Fig. 3 has been drawn assuming it to be on the endothelial cell surface.
It is unlikely that trapped erythrocytes are responsible for the observed catalysis. No hemoglobin was found in the effluent perfusate, so any trapped erythrocytes are probably located in capillaries through which perfusate is not flowing. If erythrocytes were lysed during the preparation of the isolated lung, the carbonic anhydrase so released could bind to the endothelial surface and catalyze the reactions. If this did occur, however, it probably occurs in vivo as well, and may even be the mechanism by which the enzyme gets to the endothelial surface after being manufactured elsewhere. Finally, isolated tissue preparations are likely to be somewhat edematous, although in our lungs the measured perfusion and ventilation pressures and visual inspection suggested that they were not markedly so. Interstitial carbonic anhydrase might become accessible to perfusate during pulmonary edema, perhaps as a result of the opening of intercellular spaces in the capillary endothelium.
The conclusion that isolated lung carbonic anhydrase can cause rapid equilibration ofthe H2CO3 dehydration reaction based on our direct measurements is in agreement with recent findings by indirect techniques (11, 12) in blood-free isolated rabbit lung preparations. The extent of equilibration found in the present work is closer to the 86% found in the indicator-dilution study (11) than to the 20-30% found in the steady-state CO2 excretion study (12) although conditions were not exactly the same in the different lung preparations.
Our original in vitro and computational studies (1, 2) and those ofothers (3) il.P.-71-.,:--,...lli-,W-,t-;."I"co.f,:,, by hemolysis or to enzyme located in the lung, would tend to diminish or abolish these slow pH changes.
Our first in vivo studies were not able to demonstrate slow plasma pH changes in the arterial blood of normal animals, although they were easily found in carbonic anhydrase-inhibited animals (4) . Further recent animal work, however, has led to the observation that the slow pH changes do exist but are of smaller magnitude than originally predicted (5, 6) . These data are not inconsistent with Klocke's finding (12) of 20-30% equilibration because of isolated lung carbonic anhydrase activity, but they are incompatible with the conclusion of the present work and that of Effros et al. (11) that the effluent perfuste from isolated lungs has almost reached equilibrium by the time it leaves the pulmonary capillaries. The reasons for these apparent discrepancies are not clear, but they probably include the many inherent factors that make it difficult to directly apply data obtained in isolated organ studies to in vivo situations, as well as species differences. Further work on both isolated lung and in vivo preparations will be necessary to resolve these questions and to determine the importance of the slow postcapillary plasma pH changes in normal animals. The slow pH changes occur as predicted in carbonic anhydraseinhibited animals possibly because the inhibitors can affect lung as well as erythrocyte carbonic anhydrase.
